Home › Funds › Balyasny Asset Management › DMAC
Balyasny Asset Management position in DMAC
DiaMedica Therapeutics Inc · Health Care
Latest position (Q4 2025)17.09K sh
Reported value held$136.00K
Portfolio Weight0.00%
First reportedQ4 2024
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 14.58K | $79.17K | New |
| Q1 2025 | 25.27K | $95.77K | Add |
| Q4 2025 | 17.09K | $136.00K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DMAC
- COOPERMAN LEON G 3.45M sh · $24.29M · Q2 2026
- BlackRock Inc 2.25M sh · $15.86M · Q2 2026
- GEODE CAPITAL MANAGEMENT, LLC 894.12K sh · $6.30M · Q2 2026
- Geode Capital Management 894.12K sh · $6.30M · Q2 2026
- MILLENNIUM MANAGEMENT LLC 845.31K sh · $5.95M · Q2 2026
- Millennium Management 845.31K sh · $5.95M · Q2 2026
- Vanguard Group 723.12K sh · $5.76M · Q4 2025
- Bleichroeder LP 382.32K sh · $2.69M · Q2 2026
- VANGUARD CAPITAL MANAGEMENT LLC 355.52K sh · $2.50M · Q2 2026
- Northern Trust Corp 327.52K sh · $2.31M · Q2 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 251.67K sh · $1.77M · Q2 2026
- LPL Financial LLC 233.50K sh · $1.64M · Q2 2026